Welcome to LookChem.com Sign In|Join Free
  • or
N-{1-[2-(dimethylamino)-2-oxo-1-phenylethyl]azepan-4-yl}-N-[4-fluoro-3-(trifluoromethyl)benzyl]-1-methyl-1H-imidazole-4-carboxamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1031291-58-3

Post Buying Request

1031291-58-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1031291-58-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1031291-58-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,1,2,9 and 1 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1031291-58:
(9*1)+(8*0)+(7*3)+(6*1)+(5*2)+(4*9)+(3*1)+(2*5)+(1*8)=103
103 % 10 = 3
So 1031291-58-3 is a valid CAS Registry Number.

1031291-58-3Downstream Products

1031291-58-3Relevant academic research and scientific papers

Highly Selective Synthesis of α-Aminoamide Utilizing an Umpolung Reaction and Characteristics of α-Hydrazonoester

Mizota, Isao,Mizukoshi, Nanami,Mizutani, Shunsuke,Nakamura, Yusuke,Shimizu, Makoto,Terasawa, Shunya

, p. 4168 - 4172 (2021)

An umpolung reaction with α-hydrazonoesters was investigated, and it was found that α-N,N-dialkylaminoamides could be directly synthesized in yields up to 92% via a concomitant rearrangement of dialkylamino groups. As an application, a short synthesis of an inhibitor of glycine type-1-transporter was accomplished via subsequent functional group transformations in 28% overall yield.

HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS

-

Page/Page column 79, (2008/12/06)

The present invention relates to a series of substituted heteroaryl amides of the Formula I, wherein HET, A, X1 -X4, and R1-R12 groups are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1031291-58-3